Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/153781
Author(s): Martins, N
Quispe, C
Kirkin, C
Senol, E
Zulug, A
Özçelik, B
Ademiluyi, AO
Oyeniran, OH
Semwal, P
Kumar, M
Sharopov, F
López, V
Les, F
Bagiu, IC
Butnariu, M
Sharifi-Rad, J
Alshehri, MM
Cho, WC
Title: Paving Plant-Food-Derived Bioactives as Effective Therapeutic Agents in Autism Spectrum Disorder
Publisher: Hindawi
Issue Date: 2021
Abstract: Autism spectrum disorder (ASD) is a neurodevelopmental disorder, where social and communication deficits and repetitive behaviors are present. Plant-derived bioactives have shown promising results in the treatment of autism. In this sense, this review is aimed at providing a careful view on the use of plant-derived bioactive molecules for the treatment of autism. Among the plethora of bioactives, curcumin, luteolin, and resveratrol have revealed excellent neuroprotective effects and can be effectively used in the treatment of neuropsychological disorders. However, the number of clinical trials is limited, and none of them have been approved for the treatment of autism or autism-related disorder. Further clinical studies are needed to effectively assess the real potential of such bioactive molecules.
DOI: 10.1155/2021/1131280
URI: https://hdl.handle.net/10216/153781
Source: Oxidative Medicine and Cellular Longevity, vol.2021:1131280
Related Information: info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FPSI-GER%2F28076%2F2017/PT
Document Type: Artigo em Revista Científica Internacional
Rights: openAccess
License: https://creativecommons.org/licenses/by/4.0/
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.1155-2021-1131280.pdf1.32 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons